Mark Bach, M.D., Ph.D.

Mark Bach, M.D., Ph.D.

Chief Medical OfficeratStructure Therapeutics· In proxies 2022–2023

Pay in FY2023+7% from the year before

Mark Bach, M.D., Ph.D. was paid $672.1K in FY2023 (Dec), up 7%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Structure Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Structure TherapeuticsPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role -17%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?